S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-08-01
|
| Series: | HemaSphere |
| Online Access: | http://journals.lww.com/10.1097/01.HS9.0000967632.68470.0a |
| _version_ | 1797279832972722176 |
|---|---|
| author | Raffaele Badolato Jean Donadieu 4whim Study Group |
| author_facet | Raffaele Badolato Jean Donadieu 4whim Study Group |
| author_sort | Raffaele Badolato |
| collection | DOAJ |
| first_indexed | 2024-03-07T16:32:39Z |
| format | Article |
| id | doaj.art-894818817ad6499ebefa6ef0e98eafaf |
| institution | Directory Open Access Journal |
| issn | 2572-9241 |
| language | English |
| last_indexed | 2024-03-07T16:32:39Z |
| publishDate | 2023-08-01 |
| publisher | Wiley |
| record_format | Article |
| series | HemaSphere |
| spelling | doaj.art-894818817ad6499ebefa6ef0e98eafaf2024-03-03T10:10:27ZengWileyHemaSphere2572-92412023-08-017e684700a10.1097/01.HS9.0000967632.68470.0a202308003-00082S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROMERaffaele Badolato0Jean Donadieu14whim Study Group21 University of Brescia & ASST Spedali Civili, Department of Clinical and Experimental Sciences, Brescia, Italy2 CHU Paris Est - Hôpital d’Enfants Armand-Trousseau, Paris, France3 Multiple Institutions, Global including, United Stateshttp://journals.lww.com/10.1097/01.HS9.0000967632.68470.0a |
| spellingShingle | Raffaele Badolato Jean Donadieu 4whim Study Group S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME HemaSphere |
| title | S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME |
| title_full | S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME |
| title_fullStr | S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME |
| title_full_unstemmed | S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME |
| title_short | S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME |
| title_sort | s180 results of a phase 3 trial of an oral cxcr4 antagonist mavorixafor for treatment of patients with whim syndrome |
| url | http://journals.lww.com/10.1097/01.HS9.0000967632.68470.0a |
| work_keys_str_mv | AT raffaelebadolato s180resultsofaphase3trialofanoralcxcr4antagonistmavorixaforfortreatmentofpatientswithwhimsyndrome AT jeandonadieu s180resultsofaphase3trialofanoralcxcr4antagonistmavorixaforfortreatmentofpatientswithwhimsyndrome AT 4whimstudygroup s180resultsofaphase3trialofanoralcxcr4antagonistmavorixaforfortreatmentofpatientswithwhimsyndrome |